Pyrimidine, l-

Acidimetric, spectrophotometric and HPLC assays were developed for determination of 2,3,5,6,7,8-hexahydro-l//-pyrido[l,2-c]pyrimidine-l,3-diones 135 (98M133). Its solubility properties were also characterized. Resolution of the enantiomers of 4-phenyl-2- 4-[4-(2-pyrimidinyl)piperazi-nyl]butyl perhydropyrido[l,2-c]pyrimidine-l,3-dione was achieved on hep-takis(2-N, V-dimethylcarbamoyl)- 6-cyclodextrines (01 JC(A)249). 

Semiempirical PM 3 MO calculations were performed on eight 4-aryl-2,3,5,6,7,8-hexahydro-l//-pyrido[l,2-c]pyrimidin-l,3-diones and on their dimers (00JPO213). In all of the calculated structures the aromatic ring is almost perpendicular to the plane of the pyrido[l,2-c]pyrimidin-l,3-dione fragment, which is in accordance with the X-ray data for 4-(4-methylphenyl) derivative. 

Characteristic H NMR data of (4a/ ,55)- and (4n5,5R)-2-substituted 5- [A-(/e/ /-butoxycarbonyl)-L-tryptophyl]amino perhydropyrido[l,2-c]pyri-midine-l,3-diones were tabulated (01JMC2219). C CPMASS NMR data of 4-(4-methoxyphenyl)perhydropyrido[l,2-c]pyrimidine were reported (00JST73). C NMR data were reported for eight 4-aryl-2,3,5,6,7,8-hexahydro-l//-pyrido[l,2-c]pyrimidin-l,3-diones in the solid state and in CDCI3 solution (00JPO213). The structure of 4-aryl-3,4-dihydro-2//-pyrido [l,2-c]pyrimidine-l,3-diones and their 2,3,5,6,7,8-hexahydro derivatives were characterized by H and C NMR data (99JHC389). Conformational analysis of 6-methyl-2,3,4,6,7,ll/)-hexahydro-l//-pyrimido[6,l-n]isoquino-lin-2-ones 138 and 139 were carried out by H and C NMR studies (97LA1165). 

Reaction of perhydropyrido[l,2-c]pyrimidin-l-one 149 with Mc2C(OMe)2 in the presence of CSA afforded tricyclic derivative 150 (01JA8851). 

Treatment of 8-azidomethylperhydropyrido[l,2-c]pyrimidin-l-one 157 with methyl triflate and catalytic hydrogenation of the azide group led to the formation of tricyclic guanidine derivative 158 (01JA8851). Hydroxy group of 149 was protected with methoxymethyl chloride, and the p-methoxybenzyl protecting group (PMB) was eliminated by treatment with DDQ. 

Hydrolysis of 3-[(2,6-dimethoxy-4-pyrimidinyl)hydroxymethyl]perhydro-pyrido[l,2-c]pyrimidin-l-iminium salts 174-177 in boiling cone. HCl afforded the appropriate 3-[(2-hydroxy-6-oxo-l,6-dihydropyrimidin-4-yl) hydroxymethyl] derivative (98TL7021, 00JA5017). 

Cyclization of l-(A -substituted aminocarbonyl)-3-[(tert-butoxycarbonyl) amino]- and -3- [Ai -(tert-butoxycarbonyl)tryptophyl]amino -2-(ethoxycar-bonylmethyl)piperidines (e.g. 188) on the action of NaH gave 2-substituted 5-(substituted amino)perhydropyrido[l,2-c]pyrimidine-l,3-diones (e.g. 159 and 189) (97JMC3402, 97MIP16, 98MI63, 0UMC2219). Cyclization could be also carried out in the presence of DBU (01JMC2219). 

Cyclocondensation of a-aryl-2-pyridylacetamides and 2-(3,4-dihydroiso-quinolin-l-yl)acetamide with Et2C03 in the presence of NaOEt in boiling EtOH afforded 4-aryl-2,3-dihydro-l//-pyrido[l,2-c]pyrimidine-l,3-diones (99JHC389) and 6,7-dihydro-4//-pyrimido[6,1 -a]isoquinoline-2,4-dione (98MIP15), respectively. 

Perhydropyrido[l,2-r]pyrimidin-l,3-ones were applied in the total synthesis of cyanobacterial hepatotoxin 7-epicylindrospermopsin (01JA8851). 

Hydroxy-L-prolin is converted into a 2-methoxypyrrolidine. This can be used as a valuable chiral building block to prepare optically active 2-substituted pyrrolidines (2-allyl, 2-cyano, 2-phosphono) with different nucleophiles and employing TiQ as Lewis acid (Eq. 21) [286]. Using these latent A -acylimmonium cations (Eq. 22) [287] (Table 9, No. 31), 2-(pyrimidin-l-yl)-2-amino acids [288], and 5-fluorouracil derivatives [289] have been prepared. For the synthesis of p-lactams a 4-acetoxyazetidinone, prepared by non-Kolbe electrolysis of the corresponding 4-carboxy derivative (Eq. 23) [290], proved to be a valuable intermediate. 0-Benzoylated a-hydroxyacetic acids are decarboxylated in methanol to mixed acylals [291]. By reaction of the intermediate cation, with the carboxylic acid used as precursor, esters are obtained in acetonitrile (Eq. 24) [292] and surprisingly also in methanol as solvent (Table 9, No. 32). Hydroxy compounds are formed by decarboxylation in water or in dimethyl sulfoxide (Table 9, Nos. 34, 35). 

Reaction of 4-cyano-3-imino-2,3,5,6,7,8-hcxahydro-l //-pyrido[ l,2-t lpyrimidin-l-one 139 with 2-chloroethyl isocyanate at gave the N-acylated pyrido[ 1,2-r]pyrimidin-l-onc 140 and tetracyclic derivative 141, respectively (Scheme 10) <1995MI41>. Similar reaction of 3-aminoA-cyano-2,4a,5,6,7,8-hcxahydro-l //-pyrido[l,2-c]pyrimidin-1-ones 142 afforded tricyclic compounds 143 (Scheme 11). Cyclocondensation of 142 with (COCl)2 yielded tricyclic compounds 144 <1995EJM525>. 

The bromine atom of 4-aryl-2-(4-bromobutyl)-2,3,5,6,7,8-hexahydro-177- ancj -perhydropyrido[l,2-c]pyrimidine-l,3-diones was displaced with 4-substituted piperazines <2002FES959, 2004APH139, 2004PHA99>. Heating 3-hydroxymethyl derivatives of epimeric 6-methyl-l,3,4,6,7,llb-hexahydro-277-pyrimido[6,l-,2]isoquinolin-2-ones 152 resulted in the formation of the 3-unsubstituted derivatives 153 by loss of CH20 (Equation 26) <1997LA1165>. 

JOC3790>, perhydropyrido[l,2-r]pyrimidin-l-ones <2002JA4950, 2005JOC1963>, 1,6,7,1 1 b-tetrahydro-2//,4//-... 

---